Healthcare Services

One of the Major Drivers of the Clinical Diagnostics Market Is the Rising Chronic Disease Incidence Driving Growth In The Clinical Diagnostics Market

March 31, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Clinical Diagnostics Market By The End Of 2030?

The clinical diagnostics market size has experienced strong growth over recent years. It is projected to expand from $81.74 billion in 2025 to $87.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. The historical growth of this market can be ascribed to factors such as the broadening of diagnostic laboratory networks, an uptick in disease screening programs, the increasing prevalence of infectious and chronic illnesses, enhancements in imaging technologies, and the rising adoption of lab-based testing.

The clinical diagnostics market size is anticipated to demonstrate robust expansion over the next few years. It is predicted to reach $115.39 billion by 2030, showing a compound annual growth rate (CAGR) of 7.1%. This projected growth is fueled by an increasing adoption of precision diagnostics, rising investments in advanced imaging systems, the expansion of home-based diagnostic testing, a growing demand for rapid diagnostic accuracy, and increased integration of AI in diagnostics. Significant trends during the forecast period include an escalating adoption of molecular and genetic diagnostics, a rising demand for rapid point-of-care testing, the growing integration of imaging and laboratory diagnostics, an expansion of automated diagnostic platforms, and an enhanced focus on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18537&type=smp

Which Market Drivers Are Supporting The Expansion Of The Clinical Diagnostics Market?

The anticipated expansion of the clinical diagnostics market is linked to the increasing occurrence of chronic illnesses. These are enduring health conditions, typically manageable rather than curable, frequently necessitating continuous medical care and restricting daily activities. The increasing widespread nature of chronic diseases stems mainly from elements like poor lifestyle choices, social and economic inequalities, and an aging demographic, all of which together heighten the likelihood of developing ailments such as heart disease, diabetes, and cancer. For chronic conditions, clinical diagnostics play a crucial role in precise diagnosis, tracking disease advancement, guiding therapeutic approaches, identifying early complications, tailoring medical interventions, evaluating risk factors, and aiding patient instruction and self-care. As an illustration, data from April 2025 by the Centers for Disease Control and Prevention (CDC), a US-based federal agency, indicated that in 2023, around 194 million U.S. adults, representing 76.4%, stated they had at least one chronic illness. The reported incidence stood at 59.5% for young adults, 78.4% for midlife adults, and 93.0% for older adults. Consequently, the growing occurrence of chronic diseases fuels demand in the clinical diagnostics market.

Which Segment Classifications Shape The Clinical Diagnostics Market?

The clinical diagnostics market covered in this report is segmented –

1) By Test: Lab Test, Imaging Test, Other Tests

2) By Product: Instruments, Reagents, Other Products

3) By End User: Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care Testing, Other End Users

Subsegments:

1) By Lab Test: Blood Tests, Urine Tests, Genetic Tests, Biopsy And Cytology Tests

2) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), CT Scan (Computed Tomography), Ultrasound, PET (Positron Emission Tomography) Scan

3) By Other Tests: Molecular Diagnostics, Point-Of-Care Tests, Pregnancy Tests, Allergy Tests

What Trends Are Advancing Progress In The Clinical Diagnostics Market?

Leading companies within the clinical diagnostics market are concentrating their efforts on creating novel products, including sophisticated liquid biopsy assays, to facilitate extensive genomic profiling of solid tumors. A liquid biopsy assay serves as a minimally invasive examination that analyzes blood samples to identify cancer-associated biomarkers, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), offering crucial information for diagnosis, tracking treatment effectiveness, and developing personalized medicine. For example, in November 2023, Illumina Inc., a US-based biotechnology company, released TruSight Oncology 500 ctDNA v2, an advanced liquid biopsy assay intended for comprehensive genomic profiling of solid tumors. This innovative assay permits the highly precise identification of genetic mutations and alterations within tumors, furnishing detailed understanding of the tumor’s molecular makeup. The assay boosts the capability to observe tumor dynamics and modify treatment plans accordingly, thereby enhancing personalized treatment approaches. It is engineered to produce swift and dependable results, which supports timely clinical decision-making and propels the field of cancer diagnostics forward.

Which Companies Are Expanding Their Footprint In The Clinical Diagnostics Market?

Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

Read the full clinical diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

How Is The Clinical Diagnostics Market Distributed Across Key Geographic Regions?

North America was the largest region in the clinical diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Clinical Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18537&type=smp

Browse Through More Reports Similar to the Global Clinical Diagnostics Market 2026, By The Business Research Company

Clinical Data Analytics Solutions Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-data-analytics-solutions-global-market-report

Clinical Workflow Solutions Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-workflow-solutions-global-market-report

Clinical Trial Management Systems Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-trial-management-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795